Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease ; volume:13 ; number:1 ; day:27 ; month:5 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (27.5.2023), 1-9, 12.2023
- Urheber
-
Cerro-Chiang, Giuliana
Ayres, Matthew
Rivas, Alejandro
Romero, Tahmineh
Parker, Sarah J.
Mastali, Mitra
Elashoff, David
Chen, Peter
Eyk, Jennifer E. Van
Wolters, Paul J.
Boin, Francesco
Zaman, Tanzira
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-35840-y
- URN
-
urn:nbn:de:101:1-2023091109083033259475
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cerro-Chiang, Giuliana
- Ayres, Matthew
- Rivas, Alejandro
- Romero, Tahmineh
- Parker, Sarah J.
- Mastali, Mitra
- Elashoff, David
- Chen, Peter
- Eyk, Jennifer E. Van
- Wolters, Paul J.
- Boin, Francesco
- Zaman, Tanzira
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis